Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

Nutrition - Pharma Stocks in the News: Embark Holdings, GNC, Vitamin Shoppe, Gilead Sciences, Pfizer

PR Newswire June 26, 2013

FDA Reviews, Acquisitions, Dividends, and Drug Study Results Highlight Solid Growth for Major Drug Companies - Research Report on Pfizer, Johnson & Johnson, Zoetis, AbbVie, and Lilly

PR Newswire June 26, 2013

Pfizer Invites Public To View And Listen To Webcast Of July 30 Conference Call With Analysts

Business Wire June 25, 2013

Zoetis Becomes Fully Independent With Acceptance of Pfizer Shares Tendered in Exchange Offer

Business Wire June 24, 2013

Pfizer Announces Preliminary Results of Zoetis Exchange Offer and Adjusts 2013 Financial Guidance(1) Solely to Reflect Impact of Exchange Offer

Business Wire June 24, 2013

Pfizer Announces FDA Acceptance for Review of Application to Expand Labeling for XELJANZ® (tofacitinib citrate) for Adults with Moderately to Severely Active Rheumatoid Arthritis to Include Inhibition of Progression of Structural Damage

Business Wire June 21, 2013

SodaStream, Statoil, Nektar Therapeutics, Johnson & Johnson and Pfizer highlighted as Zacks Bull and Bear of the Day

PR Newswire June 21, 2013

Early Morning Insight: Pfizer, Merck & Co., Johnson & Johnson, AbbVie, and Zogenix

PR Newswire June 20, 2013

Pfizer Announces Final Exchange Ratio of 0.9898 for Zoetis Exchange Offer and Automatic Extension of Offer to Midnight on Friday, June 21, 2013

Business Wire June 19, 2013

Special Offer for Shareholders of PFE, NOK, DELL and S

Marketwired June 19, 2013

Strategy Behind Our Success, We Get in Early: AAPL, PFE, GOOG and MSFT

Marketwired June 18, 2013

Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira Pharmaceuticals

PR Newswire June 17, 2013

Before the Crowd, How We Found AAPL, PFE, GOOG and MSFT

Marketwired June 17, 2013

Zoetis Set to Join S&P 500; First Horizon National to Join S&P MidCap 400; QLogic to Join S&P SmallCap 600

PR Newswire June 14, 2013

Don't Miss Gains in BAC, SIRI, S and PFE

Marketwired June 14, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on AXP, BIIB, PGE, TGT

Accesswire June 13, 2013

Start Making Profits Now With BAC, PFE, SIRI and S

Marketwired June 13, 2013

Perfect Trade Setups, How to Play S, BAC, PFE and MRK

Marketwired June 12, 2013

Pfizer Obtains $2.15 Billion Settlement from Teva and Sun for Infringement of Protonix® Patent

Business Wire June 12, 2013

Secrets to Making Money in BAC, FB, SIRI and PFE

Marketwired June 11, 2013